Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Dynamic Opioid Receptor Regulation in the Periphery.

Jeske NA.

Mol Pharmacol. 2019 Feb 5. pii: mol.118.114637. doi: 10.1124/mol.118.114637. [Epub ahead of print]

2.

Serum response factor mediates nociceptor inflammatory pain plasticity.

Gomez R, Kohler DM, Brackley AD, Henry MA, Jeske NA.

Pain Rep. 2018 May 9;3(3):e658. doi: 10.1097/PR9.0000000000000658. eCollection 2018 May.

3.

Repeat low-level blast exposure increases transient receptor potential vanilloid 1 (TRPV1) and endothelin-1 (ET-1) expression in the trigeminal ganglion.

Por ED, Sandoval ML, Thomas-Benson C, Burke TA, Doyle Brackley A, Jeske NA, Cleland JM, Lund BJ.

PLoS One. 2017 Aug 10;12(8):e0182102. doi: 10.1371/journal.pone.0182102. eCollection 2017.

4.

A-Kinase Anchoring Protein 79/150 Scaffolds Transient Receptor Potential A 1 Phosphorylation and Sensitization by Metabotropic Glutamate Receptor Activation.

Brackley AD, Gomez R, Guerrero KA, Akopian AN, Glucksman MJ, Du J, Carlton SM, Jeske NA.

Sci Rep. 2017 May 12;7(1):1842. doi: 10.1038/s41598-017-01999-4.

5.

Identification of a signaling cascade that maintains constitutive δ-opioid receptor incompetence in peripheral sensory neurons.

Brackley AD, Sarrami S, Gomez R, Guerrero KA, Jeske NA.

J Biol Chem. 2017 May 26;292(21):8762-8772. doi: 10.1074/jbc.M117.776799. Epub 2017 Apr 5.

6.

GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity.

Brackley AD, Gomez R, Akopian AN, Henry MA, Jeske NA.

Cell Rep. 2016 Sep 6;16(10):2686-2698. doi: 10.1016/j.celrep.2016.07.084. Epub 2016 Aug 25.

7.

RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers.

Hallums DP, Gomez R, Doyle AP, Viet CT, Schmidt BL, Jeske NA.

Clin Surg. 2016;1. pii: 1100. Epub 2016 Sep 1.

8.

A-kinase anchoring protein 79/150 coordinates metabotropic glutamate receptor sensitization of peripheral sensory neurons.

Szteyn K, Rowan MP, Gomez R, Du J, Carlton SM, Jeske NA.

Pain. 2015 Nov;156(11):2364-72. doi: 10.1097/j.pain.0000000000000295.

9.

Persistent Nociception Triggered by Nerve Growth Factor (NGF) Is Mediated by TRPV1 and Oxidative Mechanisms.

Eskander MA, Ruparel S, Green DP, Chen PB, Por ED, Jeske NA, Gao X, Flores ER, Hargreaves KM.

J Neurosci. 2015 Jun 3;35(22):8593-603. doi: 10.1523/JNEUROSCI.3993-14.2015.

10.

Divergence in endothelin-1- and bradykinin-activated store-operated calcium entry in afferent sensory neurons.

Szteyn K, Gomez R, Berg KA, Jeske NA.

ASN Neuro. 2015 Apr 13;7(2). pii: 1759091415578714. doi: 10.1177/1759091415578714. Print 2015 Mar-Apr.

11.

Peripheral scaffolding and signaling pathways in inflammatory pain.

Jeske NA.

Prog Mol Biol Transl Sci. 2015;131:31-52. doi: 10.1016/bs.pmbts.2014.11.016. Epub 2015 Feb 7. Review.

PMID:
25744669
12.

Tmem100 Is a Regulator of TRPA1-TRPV1 Complex and Contributes to Persistent Pain.

Weng HJ, Patel KN, Jeske NA, Bierbower SM, Zou W, Tiwari V, Zheng Q, Tang Z, Mo GC, Wang Y, Geng Y, Zhang J, Guan Y, Akopian AN, Dong X.

Neuron. 2015 Feb 18;85(4):833-46. doi: 10.1016/j.neuron.2014.12.065. Epub 2015 Jan 29.

13.

β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons.

Rowan MP, Szteyn K, Doyle AP, Gomez R, Henry MA, Jeske NA.

Mol Pain. 2014 Aug 1;10:50. doi: 10.1186/1744-8069-10-50.

14.

Activation of mu opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) via β-arrestin-2-mediated cross-talk.

Rowan MP, Bierbower SM, Eskander MA, Szteyn K, Por ED, Gomez R, Veldhuis N, Bunnett NW, Jeske NA.

PLoS One. 2014 Apr 2;9(4):e93688. doi: 10.1371/journal.pone.0093688. eCollection 2014.

15.

Phosphorylation regulates TRPV1 association with β-arrestin-2.

Por ED, Gomez R, Akopian AN, Jeske NA.

Biochem J. 2013 Apr 1;451(1):101-9. doi: 10.1042/BJ20121637.

PMID:
23360390
16.

β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel.

Por ED, Bierbower SM, Berg KA, Gomez R, Akopian AN, Wetsel WC, Jeske NA.

J Biol Chem. 2012 Oct 26;287(44):37552-63. doi: 10.1074/jbc.M112.391847. Epub 2012 Sep 5.

17.

Somatosensory scaffolding structures.

Jeske NA.

Front Mol Neurosci. 2012 Jan 23;5:2. doi: 10.3389/fnmol.2012.00002. eCollection 2012.

18.

A-kinase anchoring protein 150 mediates transient receptor potential family V type 1 sensitivity to phosphatidylinositol-4,5-bisphosphate.

Jeske NA, Por ED, Belugin S, Chaudhury S, Berg KA, Akopian AN, Henry MA, Gomez R.

J Neurosci. 2011 Jun 8;31(23):8681-8. doi: 10.1523/JNEUROSCI.0020-11.2011.

19.

AKAP150-mediated TRPV1 sensitization is disrupted by calcium/calmodulin.

Chaudhury S, Bal M, Belugin S, Shapiro MS, Jeske NA.

Mol Pain. 2011 May 14;7:34. doi: 10.1186/1744-8069-7-34.

20.

Metallopeptidase inhibition potentiates bradykinin-induced hyperalgesia.

Gomez R, Por ED, Berg KA, Clarke WP, Glucksman MJ, Jeske NA.

Pain. 2011 Jul;152(7):1548-54. doi: 10.1016/j.pain.2011.02.044. Epub 2011 Apr 1.

21.

Transient receptor potential V1 regulates activation and modulation of transient receptor potential A1 by Ca2+.

Patil MJ, Jeske NA, Akopian AN.

Neuroscience. 2010 Dec 29;171(4):1109-19. doi: 10.1016/j.neuroscience.2010.09.031. Epub 2010 Sep 25.

22.

PP2B/calcineurin-mediated desensitization of TRPV1 does not require AKAP150.

Por ED, Samelson BK, Belugin S, Akopian AN, Scott JD, Jeske NA.

Biochem J. 2010 Dec 15;432(3):549-56. doi: 10.1042/BJ20100936.

23.

17beta-estradiol rapidly enhances bradykinin signaling in primary sensory neurons in vitro and in vivo.

Rowan MP, Berg KA, Milam SB, Jeske NA, Roberts JL, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2010 Oct;335(1):190-6. doi: 10.1124/jpet.110.167445. Epub 2010 Jul 20.

24.

Contribution of TRPV1-TRPA1 interaction to the single channel properties of the TRPA1 channel.

Staruschenko A, Jeske NA, Akopian AN.

J Biol Chem. 2010 May 14;285(20):15167-77. doi: 10.1074/jbc.M110.106153. Epub 2010 Mar 15.

25.

A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1.

Jeske NA, Patwardhan AM, Ruparel NB, Akopian AN, Shapiro MS, Henry MA.

Pain. 2009 Dec;146(3):301-7. doi: 10.1016/j.pain.2009.08.002. Epub 2009 Sep 19.

26.

Roles of transient receptor potential channels in pain.

Stucky CL, Dubin AE, Jeske NA, Malin SA, McKemy DD, Story GM.

Brain Res Rev. 2009 Apr;60(1):2-23. doi: 10.1016/j.brainresrev.2008.12.018. Epub 2008 Dec 31. Review.

27.

Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.

Akopian AN, Ruparel NB, Jeske NA, Patwardhan A, Hargreaves KM.

Trends Pharmacol Sci. 2009 Feb;30(2):79-84. doi: 10.1016/j.tips.2008.10.008. Epub 2008 Dec 11. Review.

28.

Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice.

Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC.

Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18976-81. doi: 10.1073/pnas.0800466105. Epub 2008 Nov 24.

29.

Fibronectin stimulates TRPV1 translocation in primary sensory neurons.

Jeske NA, Patwardhan AM, Henry MA, Milam SB.

J Neurochem. 2009 Feb;108(3):591-600. doi: 10.1111/j.1471-4159.2008.05779.x. Epub 2008 Nov 11.

30.

Tumor necrosis factor alpha enhances the sensitivity of rat trigeminal neurons to capsaicin.

Khan AA, Diogenes A, Jeske NA, Henry MA, Akopian A, Hargreaves KM.

Neuroscience. 2008 Aug 13;155(2):503-9. doi: 10.1016/j.neuroscience.2008.05.036. Epub 2008 Jun 5.

PMID:
18582539
31.

A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1.

Jeske NA, Diogenes A, Ruparel NB, Fehrenbacher JC, Henry M, Akopian AN, Hargreaves KM.

Pain. 2008 Sep 15;138(3):604-16. doi: 10.1016/j.pain.2008.02.022. Epub 2008 Apr 1.

32.

Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization.

Akopian AN, Ruparel NB, Jeske NA, Hargreaves KM.

J Physiol. 2007 Aug 15;583(Pt 1):175-93. Epub 2007 Jun 21.

33.

Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons.

Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, Hargreaves KM.

J Biol Chem. 2006 Oct 27;281(43):32879-90. Epub 2006 Sep 5.

34.

Prolactin modulates TRPV1 in female rat trigeminal sensory neurons.

Diogenes A, Patwardhan AM, Jeske NA, Ruparel NB, Goffin V, Akopian AN, Hargreaves KM.

J Neurosci. 2006 Aug 2;26(31):8126-36.

35.

The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin.

Patwardhan AM, Jeske NA, Price TJ, Gamper N, Akopian AN, Hargreaves KM.

Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11393-8. Epub 2006 Jul 18.

36.

Modulation of bradykinin signaling by EP24.15 and EP24.16 in cultured trigeminal ganglia.

Jeske NA, Berg KA, Cousins JC, Ferro ES, Clarke WP, Glucksman MJ, Roberts JL.

J Neurochem. 2006 Apr;97(1):13-21. Epub 2006 Mar 3.

37.

Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors.

Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, Hargreaves KM.

J Neurosci. 2005 Sep 28;25(39):8825-32.

38.
39.

Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion.

Price TJ, Louria MD, Candelario-Soto D, Dussor GO, Jeske NA, Patwardhan AM, Diogenes A, Trott AA, Hargreaves KM, Flores CM.

BMC Neurosci. 2005 Jan 24;6:4.

40.
41.

EP24.15 is associated with lipid rafts.

Jeske NA, Glucksman MJ, Roberts JL.

J Neurosci Res. 2003 Nov 1;74(3):468-73.

PMID:
14598323

Supplemental Content

Loading ...
Support Center